Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DRDX09
|
|||
| Drug Name |
mRNA-1195
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Epstein barr virus infection [ICD-11: 1C80; ICD-9: 75] | Phase 1 | [1] | |
| Company |
Moderna
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05831111) A Phase 1, Randomized, Observer-Blind, Placebo-Controlled, 2-Part, Dose-Ranging Study of an EBV Candidate Vaccine, mRNA-1195, in Healthy Adults 18 to 55 Years of Age. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.